Inflammatory markers in Eisenmenger syndrome and their association with clinical outcomes. A cross-sectional comparative study-Reference-Cited by-同舟云学术

Inflammatory markers in Eisenmenger syndrome and their association with clinical outcomes. A cross-sectional comparative study

Published:2021-11 Issue: Volume:342 Page:34-38
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Gonzaga Laion R.A.,Gomes Walter J.,Rocco Isadora S.,Matos-Garcia Bruna C.,Bublitz Caroline,Viceconte Marcela,Tatani Solange B.,Santos Vinicius B.,Silva Célia M.C.,Tulloh Robert,Arena Ross,Guizilini Solange

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Haemodynamic definitions and updated clinical classification of pulmonary hypertension;Simonneau;Eur. Respir. J.,2019

2. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

3. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension;Beghetti;J. Am. Coll. Cardiol.,2009

4. Effects of acute oxygen supplementation on functional capacity and heart rate recovery in Eisenmenger syndrome;Gonzaga;Int. J. Cardiol.,2017

5. Inflammatory markers are elevated are in Eisenmenger syndrome;Ramakrishnan;Pediatr. Cardiol.,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leukotriene B4 levels in CHD-associated paediatric pulmonary hypertension;Cardiology in the Young;2024-03-06

2. Synemin promotes pulmonary artery smooth muscle cell phenotypic switch in shunt‐induced pulmonary arterial hypertension;ESC Heart Failure;2022-06-29